IN a previous paper the writer (Cohen, 1949) proposed a biological dosage unit, the "roentgen equivalent clinical" (rec) based on an empirical formula D = E.a.Tn.L-q, relating the physical dose in roentgens (D) to the biological dose in rec (E), taking into account the relative biological efficiency of radiation of various qualities (a), the over-all time in days (T), and the field size in decimetres (L). The physical and biological doses could be equated when the specific ion-density is minimal (a = 1), the treatment is completed in 1 day (T = 1), and the field diameter is 1 dm. (L = 1). The rec was then defined as the biological effect of 1 r of y-rays delivered through a 1 decimetre diameter field in 1 day. The parameters n and q were assumed to be constants, independent of the other factors, and their magnitudes were tentatively estimated. For the skin erythema reaction E = 1000 rec, and n q = 0.33; while for the epidermoid cancer lethal effect E = 3200 rec, n = 022 and q = 0. Since then many hundreds of cases were treated with doses calculated on this basis, and of these only a few developed reactions which differed remarkably from expectation. However, the scheme is based on assumptions and simplifications, the validity of which is by no means obvious.
Observations on Skin Reactions. A total of 150 consecutive cases (25 in each qualitative group), in which the skin dose could be accurately computed were selected for analysis. In order to eliminate uncertainties due to exit doses and the effect of contiguous fields, only those cases treated by a single field were used. In each case note was taken of the skin dose received (D), the over-all time (T), the field diameter (L), and an estimate of the biological dose (E). D was taken as the maximum surface dose at the centre of the treated field; T is the total treatment time in days irrespective of the manner of fractionation, though in the majority of cases treatment was daily for five days a week; L, in the case of square or circular fields, is the diameter in decimetres, while with irregular fields the equivalent diameter of a circle having the same ratio of area: perimeter is taken, so that L = --x Area Perimeter' and E could be estimated with a fair degree of precision from the intensity of the observed skin erythema.
Early experiments had shown a rough correlation between the dose delivered and the observed reaction. It had been noted (Sievert, 1947) that if the threshold erythema dose (1°E) were determined, then delivery of twice this dose produced a dry desquamative reaction (2°E), three times this quantity gave a moist epidermitis (3°E), and four erythema doses caused necrosis. In our series of cases the reactions were classified in these four categories, and further subdivided into weak, medium or strong reactions in each major category, thus giving 12 distinct gradations of response. It was considered that the four degrees of reaction correspond to biological doses of 1000, 2000, 3000 and 4000 rec respectively, and the intermediate gradations were evaluated by subtracting 300 rec for weak, and adding 300 rec for strong reactions in each category. For example, a strong dry desquamative reaction would be classified as E = 2300 rec. In this way a quantitative value can be assigned to any observed intensity of skin erythema in steps of 300 units. Although subjective judgment must enter into this type of assessment, the error is unlikely to be greater than one step, that is about 30 per cent for first-degree reactions, and less than 10 per cent for the more intense reactions. The dose which would produce a standard erythema in each case, under the conditions of treatment, is given by the ratio of the physical dose (D) to the observed biological dose (E). According to our formula, this ratio, designated (R) in Table I , should, within the limits of error and variation, equal a. Tn.L-q.
It then becomes possible to estimate a, n and q simultaneously by fitting the data, grouped according to quality, to the line log R =log a+ n logT-q log L The same procedure was applied to each of the six qualitative groups, estimating in each case the values of a, n and q, and their confidence limits. Preliminary results showed that whereas a varied considerably from one quality to another, showing a definite decrease with diminishing half-value layer, n and q appeared to range about 0.3 without any special trend related to quality, and within each group n and q were sufficiently close, well within the limits of observational error, to warrant the assumption that for practical purposes n = q.
The postulate that n = q simplifies the iso-effect formula to -= a , which has many important implications. Firstly it lends theoretical support to the hypothesis of a "diffusible substance" (Grynkraut and Sitkowski, 1936; Jolles, 1950) "a"* "n"* "f2." range (95% cases).
It should be noted that the quality factor for radium applies to surface moulds, implants and intracavitary treatments; it is probable, however, that with teleradium therapy the value obtaining at greater depths may be appreciably altered on account of the softening of y-rays by scattering within the tissues. In the case of Chaoul radiation the value of a = 0.49 is larger than the writer's previous estimate (Cohen, 1949) of a = 0.3 for low voltage radiation; this may be partly due to the high inherent filtration (0.2 mm. Ni), and possibly also to the average surface dose being somewhat lower than the nominal dose. The general validity, however, of the three quality factors given above, is graphically illustrated by the scatter diagrams and regression lines in Fig Values for n range from 0.28 to 0.35 and tend to increase as the energy of the radiation is diminished. The differences between these values, even that between the smallest and greatest of them, are not significant (p = 0-25); but the constant trend through the whole series of five comparisons is probably not fortuitous (p 2-5 = 0.03). Although it would be of theoretical interest to confirm this dependence of the time-area factor on the quality of the radiation, especially as a contrary trend has recently been detected in another experiment (Quastler, 1950, personal communication) , it is of little clinical importance, and there is no reason to depart from the convenient figure n-0.33 originally assigned. In comparing these results with other published data, it is necessary to note inevitable differences in the definition of the erythema dose. From the method we have used the standard erythema dose is that which, delivered to a 10 cm. field in one sitting, produces a "moderate " erythema in 50 per cent of the treated cases. With the same dose, however, some slight reddening would be visible in considerably more than half (probably 90 per cent) of the treated cases.
Since this type of " barely perceptible reaction" is a convenient and objective end-point much favoured in erythema studies, there is obviously need for care in comparing such results. It is also necessary to distinguish the transient reddening (Fruiherythems) appearing within 24 hours of the delivery of quite small doses (Helmke, 1949) from the main reaction (Haupterythems), which reaches its maximum about three weeks after treatment.
For example, the threshold erythema dose (TED) is defined (MacComb and Quimby, 1937) as that quantity of radiation giving a faint reddening of the skin, visible in two to four weeks, in 80 per cent of treated cases. It would, therefore, differ little from our standard erythema; hence the fair agreement between our results and the threshold erythema data in Fig. 2 . On the other hand in Tod's (1950) experiment, the median erythema dose for a 3 cm. diameter field treated at 140 kV with 2 mm. A1 filtration (practically identical to our group "e ") was only 275 r, the reactions being observed during the first day. This "Friiherythems" is obviously not in agreement with our results or with the figures of MacComb and Quimby (1937); but examination of the same experimental data shows that their actual TED, for which 80 per cent of reactions remain visible after one month, is over 500 r (a very satisfactory agreement). The importance of basing comparative erythema studies on the true "Haupterythems," visible in the third week after treatment, is emphasized.
Curability of Epithelioma.
From an analysis of published data on the optimum dosage for squamous epithelioma in various situations, the (biological) curative dose appeared to range from 2500 rec to 4000 rec with an average value of 3250 (Cohen, 1949) .
Similarly, the recovery exponent (n) was estimated, largely on the basis of Strand-qvist's (1944) observations, as equal to 0.22. It was felt, however, that these important constants could be evaluated within closer limits by an analysis of the results of treated cases in which the tumour dose, the over-all time, and the relative biological efficacy of the radiation used, were all precisely known.
For this purpose 100 cases of epidermoid cancer in various sites were tabulated and the results analysed statistically. It was necessary to select cases in which not only was the minimum tumour dose known with certainty, but a sufficient follow-up was obtained to enable one to decide whether the lesion had in fact been cured. The customary five-year-cure policy could not be applied since estimates of depth-doses from treatment records prior to 1945 are not sufficiently accurate for our purpose. It was decided instead to use, as a standard criterion, freedom from perceptible recrudescence for not less than three years. The records of 100 suitable cases treated between 1946 and 1948, and followed with periodic examinations through 1950, were abstracted and the data collected in Table III . The cases are arranged in order of increasing biological dosage (rec).
The dosage data shown are the true mimimum tumour doses, and differed, especially with superficial therapy, from the nominally given doses. In the case of very superficial tumours treated with lightly filtered radiation the significant point was taken to be 5 mm. below the edge of the treated field. With 2 mm. A1 filter this point receives about 85 per cent of the given dose; and with the Chaoul apparatus, only 67 per cent. With deeper growths treated at higher voltages, standard depth-dose tables were used to assess the tumour dose; while with radium applicators and implants dosage was calculated on the Paterson-Parker system.
Since various qualities of radiation were used, it was necessary to correct the dosage by a factor (RBE) which, taking that for y-rays as unity, becomes 0.5 for superficial therapy, and 0.7 for the 200 kV range (Table II For the purpose of correlating the probability of cure with dosage, the 100 cases were divided, in order of increasing dosage, into the five equal groups shown in TableIII. The average dose received by each group was determined (on account of some outlying values the median dose was taken in preference to the mean), and the number of cured cases in the group was counted. In Fig. 3 each 4000  4100  3400  4200  9500  5000  4000  4250  8000  5200  4200  3800  2500  6000  5200  5100  6000  6000  6000 (Paterson, 1948) .
In Fig. 4 the same data are charted on lognormal probability co-ordinates, the ordinate representing the percentage cured. The straight line obtained proves the almost perfect lognormality of the grouped data. dose is seen to be about 3000 rec (in good agreement with previous estimates), and the uncertainty factor is 1.3. The inset in Fig. 4 illustrates a method for determining the recovery exponent (n) by a graphical solution. Various values of n ranging from zero to 0.5 were selected, and the resultant estimates of biological dose tabulated in a manner were similarly charted in lognormal probability graphs, and the values of the standard deviation factor (f) corresponding to each value of n was determined.
It is seen that f is a minimum as n approximates 0-25. The disadvantage of this graphical method, which is otherwise simple and sufficiently accurate for practical purposes, is that it furnishes no means for computing the variance of n. It is, therefore, impossible to test the agreement between our rough estimate of n = 0.25 and similar data from other sources, e.g., Strandqvist's (1944) Therapeutic Ratio. The object of this investigation is to determine the optimum dose for the treatment of epidermoid cancer. For this purpose it is necessary to deliver that dose which will give the largest proportion of tumour regressions, and yet rarely or never exceed the limits of skin tolerance. It has been shown that a standard erythema reaction is given in the average case by 1000 rec, and in 95 per cent of cases the dose lies between ± 25 per cent of this value (that is, 800 to 1250 rec).
An erythema would be encountered in less than 2 per cent of cases receiving 750 rec or lower; and the same proportion of cases, therefore, might be expected to develop necrosis with 3000 rec. Estimated on the basis of the iso-effect formula, then 3000 rec can be accepted as the skin tolerance dose, with a risk of necrosis of under 2 per cent.
The probability of curing an irradiated tumour increases with increasing dosage up to a maximum of 95 per cent at a dose of 4000 rec (Fig. 3) , beyond which the supralethal effect becomes increasingly menacing. It is, therefore, advisable to exceed the mean lethal dose of 3000 rec whenever possible by a factor approaching two standard deviations (30 per cent), remaining, of course, within the bounds of the skin tolerance.
The ratio of skin tolerance to mean lethal dose has been defined as the therapeutic ratio; and the writer has shown (Cohen, 1949 ) that this ratio can be varied within wide limits by a judicious selection of field-size and over-all time. It was pointed out that the therapeutic ratio must always be greater than unity and, if the radiation is not absolutely homogeneous, should exceed the heterogeneity factor. When the therapeutic ratio equals 100, the skin tolerance dose is identical to the mean tumour lethal dose, so that the MLD cannot be exceeded, and a cure rate of not more than 50 per cent can be expected. It has been shown that the maximum probability of cure is given by a tumour dose of 1.3 MLD's.
In general, therefore, the optimum combination of time and area is that which gives a therapeutic ratio of not less than 1.3, in which case the probability of cure may approach 95 per cent. The time and area factors corresponding to a given therapeutic ratio can be determined from the author's nomogram (Cohen, 1949) , of which a modified version is reproduced in Fig. 5 .
It has been asserted that the prognosis is proportional to the therapeutic ratio. Since the probability of cure is dependent both on this ratio and on the variance of the MLD, the statement can be expressed quantitatively in the form 0 log 0 = H.fc or c -log f'
'~~~log f' where 0 is the therapeutic ratio obtaining with a given combination of field-size and treatment time, H is the heterogeneity factor, equal to the ratio of the maximum tissue dose to the minimum tumour dose, and f is the standard deviation factor, equal to 1.15 for our data.
It is then possible to calculate c the normal deviate, with which is associated a definite probability. The probability of cure, corresponding to any given value of c, can be determined from statistical tables or from the ordinates of Fig. 4 .
It will be noted that c = 0 corresponds to a cure rate of 50 per cent; c = 1 to 85 per cent; and c = 2 to 97.5 per cent. In this way a definite prognosis, as far as the primary growth is concerned, can be assigned to any epithelioma of known size treated, over a given number of days, to the limits of skin tolerance.
SUMMARY.
A statistical analysis of the intensity of the skin reaction in 150 cases, and its dependence on the time (T), field-size (L), and the biological efficacy (a) of the radiation used, confirmed the general validity of the simplified "iso-effect" formula D = E .a. (). By means of the method of least squares, estimates of a and n for six different qualities of radiation were obtained, and shown to be in good agreement with previously established data. The uncertainty factor in dosage estimated on this basis ranged from 1.21 to 1-35.
A further 100 cases of epidermoid cancer were similarly analysed in order to determine the dependence of curability on the biological dose. The median lethal dose for this tumour (3000 rec) and its uncertainty factor (1.3) were determined, and it was shown that, under optimal conditions of time and area, 95 per cent of tumours could be cured with a dose exceeding the median lethal dose by 30 per cent. It has also been demonstrated that the prognosis is a mathematical function of the therapeutic ratio.
The author wishes to acknowledge the valuable advice given by Mr. J. E. Kerrich, Department of Mathematics, University of the Witwatersrand, and his generous assistance with the statistical portion of this work. In particular he has examined the graphical method for determining the recovery exponent (n) for epidermoid cancer, and considers the operation mathematically legitimate and reasonably accurate. STATISTICAL NOTE BY J. E. KERRICH.
From the data in Table III Dr. Cohen suggests that biological dose = dose/ RBE x Tn, or X = Z/Tn say, where X-biological dose, Z-dose/RBE, T = time in days. He goes on to show that if X is the exact dose necessary to effect a cure, then a reasonable assumption is that log X = log Z -n log T is normally distributed.
Writing x = log X, z = log Z, t = log T this hypothesis becomes x = z -nt is normally distributed with, say, mean oc and variance a2. By a neat graphical method he proceeds to estimate ac, n and a. The disadvantage of his method is that it affords no clue as to the reliability of his estimates. To study this question of reliability we must employ an algebraic method. The sizes of the estimated standard deviations show that none of the constants can claim to be very "well determined." It must, however, be remembered that we are not dealing with a planned experiment, but that the author had to use the data that were to hand. As a suggestion to future workers in this field, more observations for small values of t (say t 0) and large values of t (say t -1.5) would help greatly in fixing c and n more accurately.
In more detail, the estimated covariance matrix is var. (oc) -001292 coy (oc, n) = -000955 coy (oc, a) = -000383 var (n) -+ -000813 coy (n, a) -+ -000227 var (a) = -000348
The mean value of x is oc. We estimate that this lies between 3.4642 i .0718
with 5 per cent risk. This makes our estimate of median X to be 2912 rec with a 5 per cent uncertainty factor of 1.180. If x is greater than oc + 2a, then the cure rate should be 97.5 per cent or more.
Our estimate of oc + 2a is 3.6060 i .0679, and the corresponding biological dose is X = 4036 rec with a 5 per cent uncertainty factor of 1.169.
Our thanks are due to the computing staff of the National Institute of Personnel Research for their help in preparing this note.
